Debra Frimerman leads legal, licensing, intellectual property, insurance, and compliance for Calyxt Inc., a plant-based tech company in Roseville. She works with the board of directors to advise on topics such as public company governance, risk and crisis management, executive compensation, and cybersecurity, and she has developed a strategy to monetize intellectual property and work with the FDA to launch the first gene-edited food product. At Syngenta, her work included $1 billion of cross-licenses to resolve a dispute and navigating industry consolidation.